Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

Please share Science & Enterprise

Light-Activated Treatment Kills Covid-19 Nasal Viruses

Red laser beam

Clinical trial findings show a light-activated disinfectant process kills SARS-CoV-2 viruses in the nose causing Covid-19 infections without harming nasal tissue. . . . → Read More: Light-Activated Treatment Kills Covid-19 Nasal Viruses

New Venture Funds to Back Life Science, Tech Start-Ups

Investor screen

Three new venture funds are seeking to invest up to $6.3 billion in start-up companies with advances in life sciences, health care, energy, and information technologies. . . . → Read More: New Venture Funds to Back Life Science, Tech Start-Ups

Biotech, Academic Lab Partner on Microbiome-Safe Products

Spray bottle

A biotechnology company creating products for gut health and a university immunology lab are evaluating cleaning products for potential damage to human protective tissues. . . . → Read More: Biotech, Academic Lab Partner on Microbiome-Safe Products

Nasal Spray Vaccine Shown to Stop Gonorrhea Infections

Neisseria gonorrhoeae bacteria

A vaccine against gonorrhea given as a nasal spray is shown to generate protective immune responses in lab mice of both sexes, and in females similar to an intravaginal vaccine. . . . → Read More: Nasal Spray Vaccine Shown to Stop Gonorrhea Infections

Environmental Biomarker Start-Up Gains $16M in Early Funds

Human body hair sample

A new company developing diagnostics for neurological and other disorders based on environmental exposures is raising $16 million in venture funds. . . . → Read More: Environmental Biomarker Start-Up Gains $16M in Early Funds

CEPI Assessing Advanced RNA Nanoparticle Vaccine

Zika virus

An international health organization is evaluating a new type of vaccine made with biodegradable RNA nanoparticles to help head off future viral pandemics. . . . → Read More: CEPI Assessing Advanced RNA Nanoparticle Vaccine

Nanotech Enzyme Process Boosts T-Cell Cancer Therapies

T-cells and cancer cells

A bioengineering team devised techniques for feasibly adding cancer-killing enzymes to engineered immune cells that in lab mice kill solid-tumor and blood cancer cells. . . . → Read More: Nanotech Enzyme Process Boosts T-Cell Cancer Therapies

Biotech Alliance Creating Circular RNA Cancer Drug

Cancer on clipboard

A partnership of biotechnology components and therapy companies aims to develop new drugs made from circular forms of RNA, starting with a colorectal cancer treatment. . . . → Read More: Biotech Alliance Creating Circular RNA Cancer Drug

Protein Chemistry Biotech Gains Collaboration, Venture Funds

DNA molecule model

An enterprise discovering new drugs with optical light-based protein chemistry is emerging from stealth, including work with biopharmaceutical company Genentech. . . . → Read More: Protein Chemistry Biotech Gains Collaboration, Venture Funds

Company Started for Gene Editing Rare Inherited Diseases

Mitochondria illustration

A new enterprise is formed to develop gene-editing therapies for mitochondrial disorders, rare inherited mutations in the energy centers of cells. . . . → Read More: Company Started for Gene Editing Rare Inherited Diseases